- Home
- QNCX vs LODE Comparison
QNCX vs LODE Comparison
Compare QNCX & LODE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- LODE
- Stock Information
- Founded
- QNCX 2012
- LODE 2008
- Country
- QNCX United States
- LODE United States
- Employees
- QNCX N/A
- LODE N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- LODE Major Chemicals
- Sector
- QNCX Health Care
- LODE Industrials
- Exchange
- QNCX Nasdaq
- LODE Nasdaq
- Market Cap
- QNCX 85.9M
- LODE 119.2M
- IPO Year
- QNCX 2019
- LODE N/A
- Fundamental
- Price
- QNCX $1.61
- LODE $2.95
- Analyst Decision
- QNCX Strong Buy
- LODE Hold
- Analyst Count
- QNCX 6
- LODE 1
- Target Price
- QNCX $8.00
- LODE $4.00
- AVG Volume (30 Days)
- QNCX 137.7K
- LODE 1.0M
- Earning Date
- QNCX 11-12-2025
- LODE 10-21-2025
- Dividend Yield
- QNCX N/A
- LODE N/A
- EPS Growth
- QNCX N/A
- LODE N/A
- EPS
- QNCX N/A
- LODE N/A
- Revenue
- QNCX N/A
- LODE $3,280,749.00
- Revenue This Year
- QNCX N/A
- LODE $16.44
- Revenue Next Year
- QNCX N/A
- LODE $800.34
- P/E Ratio
- QNCX N/A
- LODE N/A
- Revenue Growth
- QNCX N/A
- LODE 58.55
- 52 Week Low
- QNCX $0.69
- LODE $1.67
- 52 Week High
- QNCX $2.45
- LODE $10.10
- Technical
- Relative Strength Index (RSI)
- QNCX 49.14
- LODE 60.39
- Support Level
- QNCX $1.56
- LODE $2.82
- Resistance Level
- QNCX $1.67
- LODE $3.03
- Average True Range (ATR)
- QNCX 0.07
- LODE 0.15
- MACD
- QNCX 0.00
- LODE 0.09
- Stochastic Oscillator
- QNCX 69.70
- LODE 89.51
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About LODE Comstock Inc.
Comstock Inc innovates and commercializes technologies that are deployable across entire industries to contribute to energy abundance by efficiently extracting and converting under-utilized natural resources, such as waste and other forms of woody biomass into renewable fuels, and end-of-life electronics into recovered electrification metals. Comstock's innovations group is engaged in developing and using artificial intelligence technologies for advanced materials development.